Strategy Asset Managers LLC Amgen Inc Transaction History

Strategy Asset Managers LLC

$518 Million
Q3 2024

A detailed history of Strategy Asset Managers LLC transactions in Amgen Inc stock. As of the latest transaction made, Strategy Asset Managers LLC holds 2,962 shares of AMGN stock, worth $780,131. This represents 0.18% of its overall portfolio holdings.

Number of Shares

2,962

Previous 5,723 48.24%

Holding current value

$780,131

Previous $1.79 Million 46.64%

% of portfolio

0.18%

Previous 0.35%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$309.38 - $337.38 $854,198 - $931,506	-2,761 Reduced 48.24%	2,962 $954,000
Q2 2024 Aug 02, 2024	BUY	$262.75 - $319.31 $727,817 - $884,488	2,770 Added 93.8%	5,723 $1.79 Million
Q1 2024 Apr 25, 2024	BUY	$268.87 - $324.56 $6,721 - $8,114	25 Added 0.85%	2,953 $839,000
Q4 2023 Feb 12, 2024	BUY	$255.7 - $288.46 $3,068 - $3,461	12 Added 0.41%	2,928 $843,000
Q3 2023 Nov 09, 2023	SELL	$218.65 - $271.46 $613,750 - $761,988	-2,807 Reduced 49.05%	2,916 $783,000
Q2 2023 Aug 24, 2023	BUY	$214.27 - $253.37 $73,066 - $86,399	341 Added 6.34%	5,723 $1.27 Million
Q1 2023 May 02, 2023	BUY	$225.79 - $275.2 $570,119 - $694,880	2,525 Added 88.38%	5,382 $1.3 Million
Q4 2022 Jan 13, 2023	SELL	$229.03 - $291.01 $22,903 - $29,101	-100 Reduced 3.38%	2,857 $750,000
Q3 2022 Oct 11, 2022	BUY	$224.46 - $253.15 $369,236 - $416,431	1,645 Added 125.38%	2,957 $667,000
Q2 2022 Jul 13, 2022	SELL	$230.71 - $256.74 $286,541 - $318,871	-1,242 Reduced 48.63%	1,312 $319,000
Q1 2022 Apr 11, 2022	BUY	$219.27 - $242.57 $272,552 - $301,514	1,243 Added 94.81%	2,554 $617,000
Q4 2021 Jan 14, 2022	SELL	$198.88 - $227.6 $367,132 - $420,149	-1,846 Reduced 58.47%	1,311 $295,000
Q3 2021 Dec 14, 2021	SELL	$212.27 - $248.7 $2,122 - $2,487	-10 Reduced 0.32%	3,157 $671,000
Q2 2021 Aug 04, 2021	BUY	$233.58 - $259.14 $29,664 - $32,910	127 Added 4.18%	3,167 $772,000
Q1 2021 May 12, 2021	BUY	$221.91 - $258.6 $41,053 - $47,841	185 Added 6.48%	3,040 $756,000
Q4 2020 Feb 10, 2021	SELL	$216.38 - $257.67 $125,933 - $149,963	-582 Reduced 16.93%	2,855 $656,000
Q3 2020 Nov 03, 2020	BUY	$234.65 - $260.95 $35,666 - $39,664	152 Added 4.63%	3,437 $874,000
Q2 2020 Aug 10, 2020	BUY	$197.81 - $242.74 $112,158 - $137,633	567 Added 20.86%	3,285 $775,000
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $295,775 - $392,279	1,623 Added 148.22%	2,718 $551,000
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $207,184 - $266,304	1,095 New	1,095 $264,000
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $26,672 - $31,265	-160 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$180.87 - $203.88 $28,939 - $32,620	160 New	160 $30,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategy Asset Managers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategy Asset Managers LLC with notifications on news.

Account

Strategy Asset Managers LLC Amgen Inc Transaction History